Exact Sciences (EXAS) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Exact Sciences (EXAS) PT Raised to $20 at Jefferies
July 27, 2016 8:38 AM EDTJefferies analyst Brandon Couillard reiterated a Buy rating and raised his price target on Exact Sciences (NASDAQ: EXAS) to $20.00 (from $13.00) following strong Q2 results.
Couillard commented, "EXAS delivered an exceptionally strong 2Q that exhibited positive progress on essentially every key... More



